Quality Assurance of Positron Emission Tomography/Computed Tomography for Radiation Therapy

International Journal of Radiation Oncology Biology Physics

Volumn 71, Issue 1 SUPPL., 2008, Pages

  Xing, Lei ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Image guided radiation therapy; Molecular imaging; Positron emission tomography; Quality assurance; Single photon emission computed tomography

Indexed keywords

DOSIMETRY; POSITRON EMISSION TOMOGRAPHY; QUALITY ASSURANCE; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; THREE DIMENSIONAL; TUMORS;

BIOLOGIC IMAGE GUIDED RADIATION THERAPY; IMAGE GUIDED RADIATION THERAPY; IMAGING DATA; MOLECULAR IMAGING;

RADIOTHERAPY;

ARTICLE; IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY CONTROL; RADIOTHERAPY; SAFETY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TASK PERFORMANCE; TREATMENT PLANNING;

POSITRON-EMISSION TOMOGRAPHY; QUALITY CONTROL; RADIATION ONCOLOGY; RADIOTHERAPY, COMPUTER-ASSISTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 41749091833     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.05.091     Document Type: Article

References (42)

1. Townsend D.W., Carney J.P., Yap J.T., et al. PET/CT today and tomorrow. J Nucl Med 45 Suppl. (2004) 4S-14S
2. Czernin J., and Schelbert H. PET/CT imaging, facts, options, hopes, and questions. J Nucl Med 45 Suppl. (2004) 1S-3S
3. Vogel W.V., Oyen W.J., Barentsz J.O., et al. PET/CT: Panacea, redundancy, or something in between?. J Nucl Med 45 Suppl. 1 (2004) 15S-24S
4. Hicks R.J., Kalff V., MacManus M.P., et al. (18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer. J Nucl Med 42 (2001) 1596-1604
5. Mac Manus M.P., Hicks R.J., Ball D.L., et al. F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: Powerful correlation with survival and high impact on treatment. Cancer 92 (2001) 886-895
6. Bradley K.A., and Petereit D.G. Radiation therapy for gynecologic malignancies. Hematol Oncol Clin North Am 20 (2006) 347-361
7. Howard A., Mehta M.P., Ritter M.A., et al. The value of PET/CT in gross tumor volume delineation in lung and esophagus cancer. Int J Radiat Oncol Biol Phys 60 Suppl. (2004) S536-S537
8. Shields A.F., Grierson J.R., Dohmen B.M., et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med 4 (1998) 1334-1336
9. Buck A.K., Schirrmeister H., Hetzel M., et al. 3-Deoxy-3-[(18)F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules. Cancer Res 62 (2002) 3331-3334
10. 11C-Acetate PET imaging of prostate cancer. J Nucl Med 43 (2002) 181-186
11. Hara T., Kosaka N., and Kishi H. Development of (18)F-fluoroethylcholine for cancer imaging with PET: Synthesis, biochemistry, and prostate cancer imaging. J Nucl Med 43 (2002) 187-199
12. 11C-Choline and 2-deoxy-2-[18F]fluoro-D-glucose in tumor imaging with positron emission tomography. Mol Imaging Biol 4 (2002) 267-273
13. Hara T., Kosaka N., and Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med 39 (1998) 990-995
14. Chen X., Park R., Hou Y., et al. MicroPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts. J Nucl Med 45 (2004) 1390-1397
15. Sorger D., Patt M., Kumar P., et al. [18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): A comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors. Nucl Med Biol 30 (2003) 317-326
16. Christensen G.E., Carlson B., Chao K.S., et al. Image-based dose planning of intracavitary brachytherapy: Registration of serial-imaging studies using deformable anatomic templates. Int J Radiat Oncol Biol Phys 51 (2001) 227-243
17. Li T., Thorndyke B., Schreibmann E., et al. Model-based image reconstruction for four-dimensional PET. Med Phys 33 (2006) 1288-1298
18. Thorndyke B., Schreibmann E., Maxim P., et al. Enhancing 4D PET through retrospective stacking. [Abstract]. Med Phys 32 (2005) 2096
19. NEMA. Standards Publication NU 2-2001-Performance measurements of positron emission tomographs (2001), National Electrical Manufacturers Association, Rosslyn, VA
20. Cherry S.R., Sorenson J.A., and Phelps M.E. Physics in nuclear medicine (2003), Saunders, Philadelphia, PA
21. Bergmann H., Dobrozemsky G., Minear G., et al. An inter-laboratory comparison study of image quality of PET scanners using the NEMA NU 2-2001 procedure for assessment of image quality. Phys Med Biol 50 (2005) 2193-2207
22. Brechtel K., Klein M., Vogel M., et al. Optimized contrast-enhanced CT protocols for diagnostic whole-body 18F-FDG PET/CT: Technical aspects of single-phase versus multiphase CT imaging. J Nucl Med 47 (2006) 470-476
23. Smyczek-Gargya B., Fersis N., Dittmann H., et al. PET with [18F]fluorothymidine for imaging of primary breast cancer: A pilot study. Eur J Nucl Med Mol Imaging 31 (2004) 720-724
24. Blodgett T.M., McCook B.M., and Federle M.P. Positron emission tomography/computed tomography: Protocol issues and options. Semin Nucl Med 36 (2006) 157-168
25. Buther F., Schafers K.P., Stegger L., et al. Artifacts caused by contrast agents and patient movement in cardiac PET-CT. Nuklearmedizin 45 (2006) N53-N54
26. Nehmeh S.A., Erdi Y.E., Kalaigian H., et al. Correction for oral contrast artifacts in CT attenuation-corrected PET images obtained by combined PET/CT. J Nucl Med 44 (2003) 1940-1944
27. Berthelsen A.K., Holm S., Loft A., et al. PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients. Eur J Nucl Med Mol Imaging 32 (2005) 1167-1175
28. Dizendorf E.V., Treyer V., Von Schulthess G.K., et al. Application of oral contrast media in coregistered positron emission tomography-CT. AJR Am J Roentgenol 179 (2002) 477-481
29. Groves A.M., Kayani I., Dickson J.C., et al. Oral contrast medium in PET/CT: Should you or shouldn't you?. Eur J Nucl Med Mol Imaging 32 (2005) 1160-1166
30. Phelps M.E. PET molecular imaging and its biological applications (2004), Springer, New York
31. Nestle U., Schaefer-Schuler A., Kremp S., et al. Target volume definition for (18)F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging 34 (2007) 453-462
32. Kirov A., Danford C., Schmidtlein C., et al. Inaccuracy of fixed threshold segmentation for PET. Med Phys 33 (2006) 2039
33. Nehmeh S.A., Erdi Y.E., Pan T., et al. Four-dimensional (4D) PET/CT imaging of the thorax. Med Phys 31 (2004) 3179-3186
34. Vogel W.V., Wiering B., Corstens F.H., et al. Colorectal cancer: The role of PET/CT in recurrence. Cancer Imaging 5 Special Issue A (2005) S143-S149
35. Vogel W.V., Schinagl D.A., Van Dalen J.A., et al. Validated image fusion of dedicated PET and CT for external beam radiation therapy in the head and neck area. Q J Nucl Med Mol Imaging 2007 (2007 Mar 25) [Epub ahead of print]
36. Shen D., and Davatzikos C. HAMMER: Hierarchical attribute matching mechanism for elastic registration. IEEE Trans Med Imaging 21 (2002) 1421-1439
37. Schreibmann E., and Xing L. Image registration with auto-mapped control volumes. Med Phys 33 (2006) 1165-1179
38. Schreibmann E., Chen G.T., and Xing L. Image interpolation in 4D CT using a BSpline deformable registration model. Int J Radiat Oncol Biol Phys 64 (2006) 1537-1450
39. Pluim J.P.W., and Fitzpatrick J.M. Image registration. IEEE Trans Med Imaging 22 (2003) 1341-1343
40. Nehmeh S.A., Erdi Y.E., Pan T., et al. Quantitation of respiratory motion during 4D-PET/CT acquisition. Med Phys 31 (2004) 1333-1338
41. Xing L., Thorndyke B., Schreibmann E., et al. Overview of image-guided radiation therapy. Med Dosim 31 (2006) 91-112
42. Xing L., Siebers J., and Peall K. Challenges for image-guided radiation therapy: Framework and current research. Semin Radiat Oncol 17 (2007) 245-257